H. Lee Moffitt Cancer Center and Research Institute, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

DASH INtervention to INvestigate the Gut

Not Applicable

Recruiting

Conditions: Microbiota
Cancer

Interventions: Behavioral: standard American diet
Behavioral: DASH Diet

First Posted Date: 2020-09-04

Last Posted Date: 2025-05-21

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 112

Registration Number: NCT04538482

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients

Phase 2

Active, not recruiting

Conditions: Melanoma

Interventions: Drug: Tavo
Drug: Nivolumab
Device: OncoSec Medical Electroporation Therapy System

First Posted Date: 2020-08-26

Last Posted Date: 2025-05-06

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 17

Registration Number: NCT04526730

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Colorectal Cancer Awareness, Research and Education and Screening - Rural Expansion, Access and Capacity for Health

Active, not recruiting

Conditions: Colorectal Cancer

Interventions: Behavioral: Provider Tools
Behavioral: Provider surveys

First Posted Date: 2020-07-09

Last Posted Date: 2025-05-02

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 49

Registration Number: NCT04464668

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Evolutionary Therapy for Rhabdomyosarcoma

Phase 2

Recruiting

Conditions: Rhabdomyosarcoma

Interventions: Drug: Vincristine
Drug: Cyclophosphamide
Drug: Vinorelbine
Drug: Actinomycin D
Drug: Cyclophosphamide Pill

First Posted Date: 2020-05-14

Last Posted Date: 2025-03-17

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 28

Registration Number: NCT04388839

Locations: 🇺🇸
Connecticut Children's Medical Center, Hartford, Connecticut, United States
🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
🇺🇸
Primary Children's Medical Center/Utah, Salt Lake City, Utah, United States

and more 15 locations

Quality of Life Model for Older Patients With AML

Active, not recruiting

Conditions: Acute Myeloid Leukemia
AML, Adult

First Posted Date: 2020-05-08

Last Posted Date: 2025-05-06

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 206

Registration Number: NCT04380441

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board

Recruiting

Conditions: Incurable Disease

Interventions: Other: Evolutionary Tumor Board (ETB)

First Posted Date: 2020-04-13

Last Posted Date: 2025-03-17

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 35

Registration Number: NCT04343365

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools

Not Applicable

Recruiting

Conditions: Obesity

Interventions: Behavioral: Diabetes Prevention Program Intensive Lifestyle Intervention plus general women's health topics
Behavioral: Diabetes Prevention Program Intensive Lifestyle Intervention plus stress management training

First Posted Date: 2020-04-06

Last Posted Date: 2025-05-15

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 340

Registration Number: NCT04335799

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes

Completed

Conditions: Diffuse Large B Cell Lymphoma
Transformed Lymphoma

Interventions: Other: Handgrip strength test
Behavioral: Neuropsychological Assessment - Wechsler Test of Adult Reading (WTAR)
Behavioral: Neuropsychological Assessment - Repeatable Battery for the Assessment of Status (RBANS)
Behavioral: Neuropsychological Assessment - Color Trails
Behavioral: Neuropsychological Assessment -Stroop Color and Word Test
Behavioral: Patient Reported Outcomes Measurement Information System-29 (PROMIS-29) Questionnaire
Behavioral: European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire
Behavioral: Quality of Life (EQ-5D-5L) Questionnaire
Behavioral: PROMIS Cognitive Function 4a Questionnaire
Behavioral: Comprehensive Score for Financial Toxicity (COST) measure

First Posted Date: 2020-03-24

Last Posted Date: 2025-05-22

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 60

Registration Number: NCT04319237

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Clinical Trial of Green Tea Catechins in Men on Active Surveillance

Phase 2

Active, not recruiting

Conditions: Prostate Cancer
Prostate Adenocarcinoma

Interventions: Drug: Placebo
Drug: Sunphenon

First Posted Date: 2020-03-09

Last Posted Date: 2025-03-11

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 115

Registration Number: NCT04300855

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸
University of Kansas Cancer Center, Westwood, Kansas, United States

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

Recruiting

Conditions: Pancreatic Cancer
Pancreatic Cyst

Interventions: Other: Blood Sample collection
Other: Tissue sample collection
Other: Data collection

First Posted Date: 2020-02-19

Last Posted Date: 2025-02-06

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 1174

Registration Number: NCT04275557

Locations: 🇺🇸
Sylvester Comprehensive Cancer Center & Jackson Memorial Hospital, Miami, Florida, United States
🇺🇸
Florida Research Institute (FRI), Lakewood Ranch, Florida, United States
🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Home Terms & Conditions Privacy Policy